November 2014

Eleven Biotherapeutics Announces Additional Financing of $20 Million – FierceBiotech

Eleven Biotherapeutics Announces Additional Financing of $20 MillionFierceBiotechThe investment in Eleven consists of the sale and issuance of 1,743,680 shares of common stock at $11.47 per share, the closing bid price reported by NASDAQ on November 24, 2014, as well as the sale and issuance of warrants to purchase approximately … and more …read more

Eleven Biotherapeutics Announces Additional Financing of $20 Million – FierceBiotech Read More »

Klondex Mines Receives $10.3 Million from Exercise of Warrants – Gold Investing News

Klondex Mines Receives $10.3 Million from Exercise of WarrantsGold Investing News3 Klondex Mines (TSX:KDX 4) announced that it had received $10.3 million from 5,859,177 common share purchase warrants being exercised during October and November. In aggregate, of 7,525,560 common shares were issued in connection with the … and more …read more

Klondex Mines Receives $10.3 Million from Exercise of Warrants – Gold Investing News Read More »

Eleven Biotherap (EBIO) Reports $20M Securities Purchase Agreement – StreetInsider.com (subscription)

Eleven Biotherap (EBIO) Reports $20M Securities Purchase AgreementStreetInsider.com (subscription)The investment in Eleven consists of the sale and issuance of 1,743,680 shares of common stock at $11.47 per share, the closing bid price reported by NASDAQ on November 24, 2014, as well as the sale and issuance of warrants to purchase approximately … …read more

Eleven Biotherap (EBIO) Reports $20M Securities Purchase Agreement – StreetInsider.com (subscription) Read More »

Eleven Biotherapeutics Announces Additional Financing of $20 Million – MarketWatch

Eleven Biotherapeutics Announces Additional Financing of $20 MillionMarketWatchThe investment in Eleven consists of the sale and issuance of 1,743,680 shares of common stock at $11.47 per share, the closing bid price reported by NASDAQ on November 24, 2014, as well as the sale and issuance of warrants to purchase approximately … and more …read more

Eleven Biotherapeutics Announces Additional Financing of $20 Million – MarketWatch Read More »

Eleven Biotherapeutics Announces Additional Financing of $20 Million – Business Wire (press release)

Eleven Biotherapeutics Announces Additional Financing of $20 MillionBusiness Wire (press release)The investment in Eleven consists of the sale and issuance of 1,743,680 shares of common stock at $11.47 per share, the closing bid price reported by NASDAQ on November 24, 2014, as well as the sale and issuance of warrants to purchase approximately … and

Eleven Biotherapeutics Announces Additional Financing of $20 Million – Business Wire (press release) Read More »

NXP Semiconductors N.V. Announces Pricing of Private Offering of $1 Billion of … – Nasdaq

NXP Semiconductors N.V. Announces Pricing of Private Offering of $1 Billion of …NasdaqThe warrant transactions will be net share settled upon exercise and could therefore have a dilutive effect with respect to NXP’s common stock to the extent that the market price per share of NXP’s common stock exceeds the strike price of the warrants.

NXP Semiconductors N.V. Announces Pricing of Private Offering of $1 Billion of … – Nasdaq Read More »

NXP Semiconductors N.V. Announces Pricing of Private Offering of $1 Billion of … – CNNMoney

NXP Semiconductors N.V. Announces Pricing of Private Offering of $1 Billion of …CNNMoneyThe warrant transactions will be net share settled upon exercise and could therefore have a dilutive effect with respect to NXP’s common stock to the extent that the market price per share of NXP’s common stock exceeds the strike price of the warrants.

NXP Semiconductors N.V. Announces Pricing of Private Offering of $1 Billion of … – CNNMoney Read More »

Scroll to Top